These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15161697

  • 1. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N, Zafrakas K, Assmann V, Egen C, Riethdorf L, Riethdorf S, Berger J, Ebel S, Jänicke F, Sauter G, Pantel K.
    Clin Cancer Res; 2004 May 15; 10(10):3422-8. PubMed ID: 15161697
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D, Fuchs T, Kambakamba P, Mudduluru G, Maurer G, Post S, Tang Y, Nakada MT, Yan L, Allgayer H.
    Cancer; 2009 Oct 15; 115(20):4667-78. PubMed ID: 19569245
    [Abstract] [Full Text] [Related]

  • 3. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
    Tang Y, Kesavan P, Nakada MT, Yan L.
    Mol Cancer Res; 2004 Feb 15; 2(2):73-80. PubMed ID: 14985463
    [Abstract] [Full Text] [Related]

  • 4. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
    Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R.
    Clin Cancer Res; 2004 Nov 01; 10(21):7335-46. PubMed ID: 15534110
    [Abstract] [Full Text] [Related]

  • 5. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS, Hsieh DS, Lin YF, Wang JY, Sheu LF, Lee WH.
    Int J Urol; 2006 May 01; 13(5):573-80. PubMed ID: 16771728
    [Abstract] [Full Text] [Related]

  • 6. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
    Ueda K, Yamada K, Urashima M, Ishibashi Y, Shirai M, Nikaido T, Takahashi H, Okamoto A, Saito M, Yasuda M, Ohkawa K, Tanaka T.
    Oncol Rep; 2007 Apr 01; 17(4):731-5. PubMed ID: 17342307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
    Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH.
    Clin Cancer Res; 2008 Jan 15; 14(2):494-501. PubMed ID: 18223224
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR.
    J Natl Cancer Inst; 2005 Dec 21; 97(24):1840-7. PubMed ID: 16368946
    [Abstract] [Full Text] [Related]

  • 15. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z, Huang H, Li H, Chen W, Pan C.
    J Oral Pathol Med; 2009 Jul 21; 38(6):518-23. PubMed ID: 19473445
    [Abstract] [Full Text] [Related]

  • 16. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.
    Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K.
    Clin Cancer Res; 2005 Nov 15; 11(22):8006-14. PubMed ID: 16299229
    [Abstract] [Full Text] [Related]

  • 17. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
    Hakuma N, Betsuyaku T, Kinoshita I, Itoh T, Kaga K, Kondo S, Nishimura M, Dosaka-Akita H.
    Oncology; 2007 Nov 15; 72(3-4):197-204. PubMed ID: 18160808
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N, Agnantis NJ.
    J Exp Clin Cancer Res; 2004 Dec 15; 23(4):641-50. PubMed ID: 15743035
    [Abstract] [Full Text] [Related]

  • 20. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS, Yao CW, Loh SH, Cheng MF, Hsieh DS, Bai CY.
    Int J Gynecol Pathol; 2006 Apr 15; 25(2):140-6. PubMed ID: 16633062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.